Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Rapid aneuploidy analysis | October 7, 2022
Every year world thrombosis day is held on October 13 to bring awareness to the potential risks of developing thrombisis.
While thrombosis gets the most awareness in the general public through warnings to avoid DVT (deep vein thrombosis) while flying, aside from environental factors or injury to the circulatory system, the risk of thrombosis due to genetic factors should not be overlooked as thrombosis can affect anyone regardless of age or environmental factors. Early identification of this predisposition to form blood clots allows for appropriate prevention methodology to be applied, reducing the risk of embolism.
Devyser Thrombophilia detects the presence of 6 genetic mutations implicated in the increased risk of developing thrombophilia and venous thromboembolism. The multiplex PCR kit can identify: Factor V Leiden, Factor V R2, Prothrombin/Factor II, MTHFR C677T, MTHFR A1298C, and PAI-1/ SERPINE1 4G/5G.
